Ten patients with hepatitis B and correct errors

 Ten patients with hepatitis B following is errors and correct
into the military hospital in Beijing Ditan professor of health of the Sohu interview, very pertinent and practical, very useful for the majority of hepatitis B patients, the text contains, for patients to learn information.
Misunderstanding one: whether the disease, its own way.
errors of the two: just JiangMei, no anti-virus.
Misunderstanding number three: do not believe the hospital, but the letter ad.
errors of the four: extra worry ,-rejection drugs.
Misunderstanding Five: Australian anti-carry, over-treatment.
Misunderstanding Six: fear of mutation, not treatment.
Mistakes seven: the psychological burden, not all day long.
the eight misunderstanding : care technology, ignoring the treatment.
nine errors: Seeing with one eye, lack of nutrition.
Ten Mistakes: regardless of condition, blind negative.
chronic hepatitis B patients because not only have to face the body the pain, but also because there are certain infectious hepatitis B, to face great social and psychological pressure, so that treatment is very urgent desire. due to the current overall level of the treatment of chronic hepatitis B is not high, away from the needs of patients and requirements are very far away, led to a series of serious problems, leading to chronic hepatitis B patients in the treatment process produces a lot of errors. in some cases easier to solve, but some errors result in very serious consequences. Therefore, chronic hepatitis B patients must understand what are the errors in the treatment, how to deal with.
Misunderstanding one: whether the disease, its own way.
some patients the diagnosis of chronic hepatitis B is very clear, however, did not care for the disease, its own way in life, still do not drink wrong. This is the part of the first patients with chronic misunderstanding. a lot of clinical data and experimental results show that chronic hepatitis B patients developed cirrhosis, hepatocellular carcinoma and other end-stage liver disease is one of the risk factors alcohol. I have a diagnosis and treatment of patients with a mid-level leading cadres, early years on the diagnosis of chronic hepatitis B, but did not care, every day, heavy drinking, 1,000 grams of white wine per day, the results appeared in the 58 years of age severe liver cirrhosis, the development of hepatocellular carcinoma, liver tumors and even in that did not stop drinking when they found the liver tumor, metastatic tumors that already exists, not only lost the opportunity to surgical treatment, and even liver transplantation time to have missed. chronic hepatitis B and liver cirrhosis, hepatocellular carcinoma is closely related to the development, if drinking habits, then the development of cirrhosis and HCC will greatly enhance the chance.
responses: If you find that chronic hepatitis B, not only attach importance to regular treatment, but also to develop good habits, be sure to quit drinking habits. for hepatitis patients, a drop of alcohol is redundant, do not of luck.
errors of the two: just JiangMei, no anti-virus.
for chronic hepatitis B patients, the most fundamental cause is infected with the hepatitis B virus. Therefore, the treatment of chronic hepatitis B is the most fundamental antiviral therapy. But whether it is interferon a, pegylated interferon, or nucleoside analogues lamivudine, adefovir dipivoxil, entecavir, telbivudine, not on all of the patients have good effect. some patients the effect of antiviral therapy for loss of confidence, no antiviral treatment, only interested in protecting liver reducing enzyme treatment. because the virus has existed in the liver, without antiviral therapy to inhibit the body does not clear or hepatitis viruses, only the liver reducing enzyme treatment may be part of the patients in the period of time the disease can be temporary relief, but few will eventually cure hepatitis. Therefore, although the efficacy of antiviral therapy are not satisfied, but, after all, In some patients obtain better effect, therefore, if appropriate antiviral treatment, do not rule out the subjective antiviral treatment, otherwise they will lose the timing of treatment.
is active for replication of hepatitis B virus, hepatitis B DNA test results positive for hepatitis virus, serum aminotransferase levels greater than 2 times the upper limit of normal or more patients, according to the specific circumstances of illness and patients should be active antiretroviral therapy, not just to nourish the liver and reducing enzyme treatment. clinicians should be understand that this part of the first-line treatment in patients with interferon a and nucleoside drugs (acid) analogues. Although antiretroviral therapy is not for all the patients have significant treatment effect, however, antiviral therapy is the first one of the treatment. I have said that doctors face any anti-viral treatment for chronic hepatitis B patients, should not deprive patients with a proven effective interferon and nucleoside (acid) analogues of these rights of first-line antiretroviral therapy.
Solution: If the appropriate antiviral treatment, antiviral treatment should be timely, do not ignore the anti-viral treatment, the most important, ranked first in the treatment.
Misunderstanding number three: do not believe the hospital, but the letter ad.
due to the current regular therapy in the treatment of chronic hepatitis B is limited in effectiveness because of the regional experts on the current treatment of hepatitis B have different views, and even some hospital or individual physician awareness of errors, News media biased public opinion of doctors, patients on the doctor, a crisis of confidence, it causes some patients to hospitals and decreased trust in physicians, and therefore turn to other non-formal treatment options. with anxious patients seek treatment, the current Medical advertising management confusion, some of the ads exaggerated, resulting in some patients cheated.